Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-21

Clinical Trial Update: A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating a guideline-driven step-down approach to asthma therapy using Flutiform; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FlutiForm (fluticasone propionate/formoterol)

Snippet

Sponsor: Research in Real-Life Ltd | Conditions: Asthma | Phase 4 | Status: COMPLETED